The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 21, 2019
Filed:
Nov. 16, 2011
Applicant:
Paul A. Sobotka, West St. Paul, MN (US);
Inventor:
Paul A. Sobotka, West St. Paul, MN (US);
Assignee:
MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L., Luxembourg, LU;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 18/02 (2006.01); A61B 5/08 (2006.01); A61B 5/00 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 18/14 (2013.01); A61B 5/082 (2013.01); A61B 5/4848 (2013.01); A61B 18/02 (2013.01); A61B 18/1492 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00589 (2013.01); A61B 2018/00613 (2013.01);
Abstract
Methods for treating dyspnea with therapeutic renal neuromodulation and associated system and methods are disclosed herein. One aspect of the present technology, for example, is directed to methods that block, reduce, and/or inhibit renal sympathetic nerve activity to achieve a reduction in central sympathetic tone. Renal sympathetic nerve activity may be altered or modulated along the afferent and/or efferent pathway. The achieved reduction in central sympathetic tone may carry therapeutic benefits for patients with dyspnea.